NCT03539835

Brief Summary

This study will begin to fill a knowledge gap by determine whether changes in kynurenine metabolism occur following Resistance Training (RT) and relate to reductions in inflammation and improved behavioral and physical function as this may identify potential targets for interventions to promote cancer recovery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable cancer

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 16, 2018

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 29, 2018

Completed
7 months until next milestone

Study Start

First participant enrolled

December 10, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 9, 2020

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 12, 2020

Completed
Last Updated

July 27, 2020

Status Verified

July 1, 2020

Enrollment Period

1.2 years

First QC Date

May 16, 2018

Last Update Submit

July 24, 2020

Conditions

Keywords

Breast Cancer SurvivorsResistance TrainingFatiguePhysical FunctionBehavioral FunctionKynurenine metabolism

Outcome Measures

Primary Outcomes (1)

  • Change in fatigue assessed by Multidimensional Fatigue Inventory (MFI) score

    The Multidimensional Fatigue Inventory (MFI) is a 20-item self-report instrument designed to measure fatigue. It covers the following dimensions: General Fatigue, Physical Fatigue, Mental Fatigue, Reduced Motivation and Reduced Activity. Each scale contains four items for which the person had to indicate on a seven-point scale to what extent the particular statement applies to him or her. An equal number of items is worded in a positive and in a negative direction to counteract response tendencies.

    Baseline, 12 weeks follow up

Secondary Outcomes (14)

  • Change in depression assessed by Hamilton Depression Rating Scale (HAM-D) score

    Baseline, 12 weeks follow up

  • Change in balance test score

    Baseline, 12 weeks follow up

  • Change in muscle function assessed by Isometric Handgrip test.

    Baseline, 12 weeks follow up

  • Change in muscle function assessed by Lower Extremity Endurance test

    Baseline, 12 weeks follow up

  • Change in muscle function assessed by Lower Extremity Strength test

    Baseline, 12 weeks follow up

  • +9 more secondary outcomes

Study Arms (2)

Resistance training

EXPERIMENTAL
Other: Resistance training (RT)

Cognitively-based compassion training

ACTIVE COMPARATOR
Behavioral: Cognitively-based compassion training control (CBCT)

Interventions

Resistance training (RT) will include 15 repetitions for two sets and to exhaustion on the third set for seven major muscle groups: the leg and chest press, knee extension, leg curl, row, abdominal crunch, and bicep curl. Resistance is gradually increased to account for strength gains when subjects are able to complete 20 repetitions on the third set.

Resistance training

Cognitively-based compassion training control (CBCT) classes will be performed in a group setting for 1.5-2 hours per week, and consist of didactics, class discussion, and guided meditation practice. Each class will begin with a period of meditation to calm and focus the mind, followed by analytical practices designed to challenge unexamined assumptions regarding feelings, and actions toward others with a focus on generating spontaneous empathy and compassion for themselves and others.

Cognitively-based compassion training

Eligibility Criteria

Age50 Years - 75 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsFemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • within 6 months to 10 years post active breast cancer therapy (i.e. surgery/chemotherapy) for stage I-III invasive breast cancer,
  • at least 6 months post breast reconstruction (if applicable),
  • lack of menses for at least one year,
  • BMI 20-35 kg/m2,
  • fatigued (subjective reporting ≥3 on a 1-10 scale),
  • untrained with regard to structured resistance training (no more than 3x/week).

You may not qualify if:

  • plans for surgery (e.g., breast reconstruction) during the study period,
  • taking an anticoagulant medication (i.e. heparin, apixaban, rivaroxaban),
  • allergic to lidocaine,
  • orthopedic or chronic pain condition restricting exercise,
  • Mini-Mental Status Examination (MMSE) scores below education-specific cut-points (less than 23 for more than 9th grade education and less than 17 for less than 8th grade education),
  • unable to receive physician medical clearance.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Winship Cancer Institute

Atlanta, Georgia, 30322, United States

Location

MeSH Terms

Conditions

NeoplasmsFatigue

Interventions

Resistance Training

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Monica Serra, MD

    Emory University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 16, 2018

First Posted

May 29, 2018

Study Start

December 10, 2018

Primary Completion

March 9, 2020

Study Completion

March 12, 2020

Last Updated

July 27, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share

Locations